KABAKOFF DAVID S 4
4 · NextCure, Inc. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
KABAKOFF DAVID S
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+28,050→ 28,050 totalExercise: $1.50Exp: 2034-06-19→ Common Stock (28,050 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 20, 2025 and the date of the 2025 Annual Meeting of Stockholders.